Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs
Open Access
Abstract
Early and rapid diagnosis of drug resistance in tuberculosis (TB) plays a key role in reducing the spread of resistance and enabling effective treatment. The aim of this study was to investigate mutations in drug resistance-associated gene regions of Mycobacterium tuberculosis complex (MTBC) isolates resistant to at least two first-line anti-tuberculosis drugs through sequence analysis, in order to characterize the core molecular features of these strains in the region and to identify previously unreported, geographically distinct novel mutation sites. The drug susceptibility of 23 clinical isolates was assessed using the BACTEC MGIT 960 system, and resistance-associated point mutations were identified through DNA sequence analysis and comparison with GenBank reference sequences. AAG → AGG mutation was detected in the rpsL gene region at codon 43 (n = 7) and codon 88 (n = 1). Additionally, GAG → GCG point mutation was identified at codon 70 (n = 2), representing a new region not previously reported in the literature. The most frequent mutation was AGC → ACC at katG codon 315 (n = 10), followed by a C → T substitution at position −15 of the inhA promoter region (n = 4). Additionally, TCG → TTG at rpoB codon 531 (n = 4) and ATG → GTG at embB codon 306 (n = 1) were detected. The detection of resistance-associated mutations is essential for controlling drug-resistant tuberculosis. In this study, a novel rpsL mutation (GAG → GCG) at codon 70 and a previously unreported codon 88 mutation in our country were identified, contributing to the understanding of molecular resistance mechanisms and epidemiology.Keywords
This publication has 44 references indexed in Scilit:
- Evaluation of Mutations Related to Streptomycin Resistance in Mycobacterium tuberculosis Clinical IsolatesCurrent Microbiology, 2022
- Drug resistant Tuberculosis: A reviewComparative Immunology, Microbiology and Infectious Diseases, 2021
- Mutations in rpoB and katG genes and the inhA operon in multidrug-resistant Mycobacterium tuberculosis isolates from ZambiaJournal of Global Antimicrobial Resistance, 2020
- Repurposed drug candidates for antituberculosis therapyEuropean Journal of Medicinal Chemistry, 2020
- Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, MexicoJournal of Global Antimicrobial Resistance, 2017
- Diagnóstico rápido de la tuberculosis. Detección de mecanismos de resistenciaEnfermedades Infecciosas y Microbiología Clínica, 2017
- Frequency of rrs and rpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patientsJournal of Global Antimicrobial Resistance, 2017
- Mutations in rrs , rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from ThailandJournal of Global Antimicrobial Resistance, 2016
- rrs and rpsL mutations in streptomycin-resistant isolates of Mycobacterium tuberculosis from MexicoJournal of Microbiology, Immunology and Infection, 2013
- Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosisResearch in Microbiology, 2004